Proof of concept for gene therapy was described for the DM1 mouse model, HSA-LR, expressing a transgene with 220 CTG repeats in 3′ UTR of human skeletal actin gene (HSA). This evidence concerns the gene ALB and myotonic dystrophy type 1.